Podcast Episodes
Back to SearchPharmaceutical Executive Daily: Moderna's $140 Million Manufacturing Investment
In today’s Pharmaceutical Executive Daily, learn how Moderna is expanding its manufacturing footprint in Massachusetts, GSK is advancing new research…
11 months, 4 weeks ago
Pharmaceutical Executive Daily: FDA's Approval of Epkinly
In today’s Pharmaceutical Executive Daily, learn how Novo Nordisk is launching an introductory offer for Wegovy and Ozempic, AbbVie and Genmab gain F…
11 months, 4 weeks ago
Pharmaceutical Executive Daily: Novo Nordisk's Leadership Restructure
In today’s Pharmaceutical Executive Daily learn how Novo Nordisk is restructuring leadership to enhance scientific and commercial alignment, ABL Bio …
1 year ago
Pharmaceutical Executive Daily: WeightWatchers Planning to Offer Wegovy Following Approval
In today’s Pharmaceutical Executive Daily, WeightWatchers plans to offer Novo Nordisk’s oral Wegovy pending FDA approval, FDA unveils a new Plausible…
1 year ago
Pharmaceutical Executive Daily: Dr. Richard Pazdur Appointed as Director CDER
In today’s Pharmaceutical Executive Daily, Richard Pazdur is named director of FDA’s Center for Drug Evaluation and Research, Pfizer strengthens focu…
1 year ago
Pharmaceutical Executive Daily: AstraZeneca Becomes UK's Largest Stock
In today’s Pharmaceutical Executive Daily, AstraZeneca surpasses Shell to become the UK’s largest listed company, Basel intensifies efforts to attrac…
1 year ago
Pharmaceutical Executive Daily: Wegovy Shows Potential to Treat MASH Patients
1 year ago
Raising Biomarker Awareness
Dr. Jaspal Singh explains some of the barriers that prevent cancer patients from getting biomarker testing early in their treatment journey.
1 year ago
Pharmaceutical Executive Daily: FDA Approves Darzalex Faspro
In today’s Pharmaceutical Executive Daily, we cover the FDA’s approval of Darzalex Faspro for adults with high-risk smoldering multiple myeloma, the …
1 year ago
Pharmaceutical Executive Daily: Lilly and Novo Nordisk Bring GLP-1's to TrumpRX
In today’s Pharmaceutical Executive Daily, we cover Eli Lilly and Novo Nordisk’s plans to bring their leading weight-loss medications to the TrumpRx …
1 year ago